← Back to Clinical Trials
Recruiting NCT06899308

NCT06899308 Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06899308
Status Recruiting
Phase
Sponsor Jacobs University Bremen gGmbH
Condition Social Isolation or Loneliness
Study Type OBSERVATIONAL
Enrollment 363 participants
Start Date 2025-03-17
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 363 participants in total. It began in 2025-03-17 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of Health Surveillance is to analyze and describe the state of health of students at Constructor University, key influencing factors and individual resources by using mixed-method design.

Eligibility Criteria

Inclusion Criteria: * English language skills * Reading and writing skills * Internet access * Student status * Consent to participate in the study Exclusion Criteria: * Illiteracy * Massively limited cognitive abilities ( i.e. linguistic components of the digital offerings must be able to be used, and questionnaires completed, or interviews participated in) and severe psychiatric disorders (e.g., severe depression)

Contact & Investigator

Central Contact

Alexander Strelnikov, Dr. med.

✉ astrelnikov@constructor.university

📞 +49 421 200 4730

Principal Investigator

Sonia Lippke, PhD

PRINCIPAL INVESTIGATOR

Constructor University Bremen gGmbH & Bremen International Graduate School of Social Sciences, Germany

Frequently Asked Questions

Who can join the NCT06899308 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Social Isolation or Loneliness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06899308 currently recruiting?

Yes, NCT06899308 is actively recruiting participants. Contact the research team at astrelnikov@constructor.university for enrollment information.

Where is the NCT06899308 trial being conducted?

This trial is being conducted at Bremen, Germany, Bremen, Germany.

Who is sponsoring the NCT06899308 clinical trial?

NCT06899308 is sponsored by Jacobs University Bremen gGmbH. The principal investigator is Sonia Lippke, PhD at Constructor University Bremen gGmbH & Bremen International Graduate School of Social Sciences, Germany. The trial plans to enroll 363 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology